US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Identifieur interne : 001224 ( Main/Corpus ); précédent : 001223; suivant : 001225US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
Auteurs : Nadine Shehab ; Maribeth Lovegrove ; Daniel S. BudnitzSource :
- JAMA internal medicine [ 2168-6114 ] ; 2020.
English descriptors
- KwdEn :
- Anti-Infective Agents (pharmacology), Azithromycin (pharmacology), Betacoronavirus (MeSH), COVID-19 (MeSH), Chloroquine (pharmacology), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Databases, Pharmaceutical (statistics & numerical data), Drug Prescriptions (statistics & numerical data), Humans (MeSH), Hydroxychloroquine (pharmacology), Outpatients (statistics & numerical data), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Practice Patterns, Physicians' (trends), Pre-Exposure Prophylaxis (methods), Prescription Drug Monitoring Programs (statistics & numerical data), SARS-CoV-2 (MeSH), United States (epidemiology).
- MESH :
- chemical , pharmacology : Anti-Infective Agents, Azithromycin, Chloroquine, Hydroxychloroquine.
- geographic , epidemiology : United States.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Pre-Exposure Prophylaxis.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- statistics & numerical data : Databases, Pharmaceutical, Drug Prescriptions, Outpatients, Prescription Drug Monitoring Programs.
- trends : Practice Patterns, Physicians'.
- Betacoronavirus, COVID-19, Humans, SARS-CoV-2.
DOI: 10.1001/jamainternmed.2020.2594
PubMed: 32628242
PubMed Central: PMC7536584
Links to Exploration step
pubmed:32628242Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</title>
<author><name sortKey="Shehab, Nadine" sort="Shehab, Nadine" uniqKey="Shehab N" first="Nadine" last="Shehab">Nadine Shehab</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Lantana Consulting Group, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lovegrove, Maribeth" sort="Lovegrove, Maribeth" uniqKey="Lovegrove M" first="Maribeth" last="Lovegrove">Maribeth Lovegrove</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Budnitz, Daniel S" sort="Budnitz, Daniel S" uniqKey="Budnitz D" first="Daniel S" last="Budnitz">Daniel S. Budnitz</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32628242</idno>
<idno type="pmid">32628242</idno>
<idno type="doi">10.1001/jamainternmed.2020.2594</idno>
<idno type="pmc">PMC7536584</idno>
<idno type="wicri:Area/Main/Corpus">001224</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001224</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</title>
<author><name sortKey="Shehab, Nadine" sort="Shehab, Nadine" uniqKey="Shehab N" first="Nadine" last="Shehab">Nadine Shehab</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Lantana Consulting Group, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Lovegrove, Maribeth" sort="Lovegrove, Maribeth" uniqKey="Lovegrove M" first="Maribeth" last="Lovegrove">Maribeth Lovegrove</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Budnitz, Daniel S" sort="Budnitz, Daniel S" uniqKey="Budnitz D" first="Daniel S" last="Budnitz">Daniel S. Budnitz</name>
<affiliation><nlm:affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">JAMA internal medicine</title>
<idno type="eISSN">2168-6114</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Infective Agents (pharmacology)</term>
<term>Azithromycin (pharmacology)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Chloroquine (pharmacology)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Databases, Pharmaceutical (statistics & numerical data)</term>
<term>Drug Prescriptions (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (pharmacology)</term>
<term>Outpatients (statistics & numerical data)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Practice Patterns, Physicians' (trends)</term>
<term>Pre-Exposure Prophylaxis (methods)</term>
<term>Prescription Drug Monitoring Programs (statistics & numerical data)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Infective Agents</term>
<term>Azithromycin</term>
<term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Pre-Exposure Prophylaxis</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Pharmaceutical</term>
<term>Drug Prescriptions</term>
<term>Outpatients</term>
<term>Prescription Drug Monitoring Programs</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Practice Patterns, Physicians'</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32628242</PMID>
<DateCompleted><Year>2020</Year>
<Month>11</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>180</Volume>
<Issue>10</Issue>
<PubDate><Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>JAMA internal medicine</Title>
<ISOAbbreviation>JAMA Intern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.</ArticleTitle>
<Pagination><MedlinePgn>1384-1386</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.2594</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shehab</LastName>
<ForeName>Nadine</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Lantana Consulting Group, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lovegrove</LastName>
<ForeName>Maribeth</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Budnitz</LastName>
<ForeName>Daniel S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo><Affiliation>US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>JAMA Intern Med</MedlineTA>
<NlmUniqueID>101589534</NlmUniqueID>
<ISSNLinking>2168-6106</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D062313" MajorTopicYN="N">Databases, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065129" MajorTopicYN="N">Pre-Exposure Prophylaxis</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073958" MajorTopicYN="N">Prescription Drug Monitoring Programs</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year>
<Month>07</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>11</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32628242</ArticleId>
<ArticleId IdType="pii">2767895</ArticleId>
<ArticleId IdType="doi">10.1001/jamainternmed.2020.2594</ArticleId>
<ArticleId IdType="pmc">PMC7536584</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Am Coll Cardiol. 2020 May 26;75(20):2623-2624</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Aug 1;180(8):1116-1118</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32347895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001224 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001224 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32628242 |texte= US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32628242" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |